Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress DP Mihai, A Ungurianu, CI Ciotu, MJM Fischer, OT Olaru, GM Nitulescu, ... International Journal of Molecular Sciences 22 (13), 7183, 2021 | 17 | 2021 |
In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity C Andrei, DP Mihai, A Zanfirescu, GM Nitulescu, S Negres Pharmaceutics 14 (12), 2563, 2022 | 6 | 2022 |
The Influence of Sildenafil–Metformin Combination on Hyperalgesia and Biochemical Markers in Diabetic Neuropathy in Mice C Pușcașu, A Ungurianu, OC Șeremet, C Andrei, DP Mihai, S Negreș Medicina 59 (8), 1375, 2023 | 3 | 2023 |
Understanding the Molecular Mechanisms Underlying the Analgesic Effect of Ginger C Andrei, A Zanfirescu, GM Nițulescu, S Negreș Nutraceuticals 2 (4), 384-403, 2022 | 3 | 2022 |
Natural Active Ingredients and TRPV1 Modulation: Focus on Key Chemical Moieties Involved in Ligand–Target Interaction C Andrei, A Zanfirescu, GM Nițulescu, OT Olaru, S Negreș Plants 12 (2), 339, 2023 | 2 | 2023 |
EVALUATION OF THERAPEUTIC POTENTIAL OF CANNABIDIOLBASED PRODUCTS IN ANIMAL MODELS OF EPILEPTIC SEIZURES, NEUROPATHIC PAIN AND CHRONIC INFLAMMATION. NM Blebea, DP MIHAI, C Andrei, DM Stoica, C CHIRIȚĂ, S NEGREŞ Farmacia 70 (6), 2022 | 2 | 2022 |
Identification, analysis and prediction of valid and false information related to vaccines from Romanian tweets A Valeanu, DP Mihai, C Andrei, C Puscasu, AM Ionica, MI Hinoveanu, ... medRxiv, 2023.08. 19.23294319, 2023 | 1 | 2023 |
Cetirizine and Levetiracetam as Inhibitors of Monoacylglycerol Lipase: Investigating Their Repurposing Potential as Novel Osteoarthritic Pain Therapies C Andrei, DP Mihai, G Nitulescu, A Ungurianu, DM Margina, GM Nitulescu, ... Pharmaceuticals 16 (11), 1563, 2023 | | 2023 |
Paclitaxel—A Valuable Tool for Inducing Visceral Pain in Preclinical Testing? C Andrei, A Zanfirescu, DP Mihai, S Negreș International Journal of Translational Medicine 3 (1), 108-119, 2023 | | 2023 |